Cargando…

The Role of Alpha-2 Agonists for Attention Deficit Hyperactivity Disorder in Children: A Review

Introduction: Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common neurodevelopmental disorders, characterized by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), which is marked by symptoms such as inappropriate levels of inattention, hyperactiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neuchat, Elisa E., Bocklud, Brooke E., Kingsley, Kali, Barham, William T., Luther, Patrick M., Ahmadzadeh, Shahab, Shekoohi, Sahar, Cornett, Elyse M., Kaye, Alan D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204383/ https://www.ncbi.nlm.nih.gov/pubmed/37218982 http://dx.doi.org/10.3390/neurolint15020043

Ejemplares similares

Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder
por: Edinoff, Amber N., et al.
Publicado: (2021)

Teprotumumab-trbw as a Novel Monoclonal Antibody for Thyroid Eye Disease: A Literature Review
por: Bocklud, Brooke E, et al.
Publicado: (2023)

Lyme Disease and Post-treatment Lyme Disease Syndrome: Current and Developing Treatment Options
por: Talbot, Norris C, et al.
Publicado: (2023)

Palliative Care and Multi-Agent Systems: A Necessary Paradigm Shift
por: Brondeel, Kimberley C., et al.
Publicado: (2023)

Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology
por: Sinnathamby, Evan S., et al.
Publicado: (2023)

Chronic Administration of Melatonin: Physiological and Clinical Considerations
por: Givler, Donald, et al.
Publicado: (2023)

Acromegaly: Pathophysiological Considerations and Treatment Options Including the Evolving Role of Oral Somatostatin Analogs
por: Daniel, Charles P., et al.
Publicado: (2023)

Helicobacter Pylori: A Review of Current Treatment Options in Clinical Practice
por: Roberts, Logan T., et al.
Publicado: (2022)

Telemedicine, E-Health, and Multi-Agent Systems for Chronic Pain Management
por: Ahmed Kamal, Manar, et al.
Publicado: (2023)

The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Sagvolden, Terje
Publicado: (2006)

Attention Deficit Hyperactivity Disorder and Athletes
por: White, Russell D., et al.
Publicado: (2014)

AOD Use and Attention Deficit/Hyperactivity Disorder
por: Wilens, Timothy E.
Publicado: (1998)

VALTOCO(®) (Diazepam Nasal Spray) for the Acute Treatment of Intermittent Stereotypic Episodes of Frequent Seizure Activity
por: Cornett, Elyse M., et al.
Publicado: (2021)

The Clinically Meaningful Link Between Alcohol Use and Attention Deficit Hyperactivity Disorder
por: Smith, Bradley H., et al.
Publicado: (2002)

Compensatory mechanism of attention-deficit/hyperactivity disorder recovery in resting state alpha rhythms
por: Han, Chuanliang, et al.
Publicado: (2022)

Management of attention-deficit hyperactivity disorder
por: Verma, Rohit, et al.
Publicado: (2011)

The history of attention deficit hyperactivity disorder
por: Lange, Klaus W., et al.
Publicado: (2010)

Stigma in attention deficit hyperactivity disorder
por: Mueller, Anna K., et al.
Publicado: (2012)

Driving and attention deficit hyperactivity disorder
por: Fuermaier, Anselm B. M., et al.
Publicado: (2015)

Genetics of attention deficit hyperactivity disorder
por: Faraone, Stephen V., et al.
Publicado: (2018)

Neuroimaging in attention-deficit/hyperactivity disorder
por: Pereira-Sanchez, Victor, et al.
Publicado: (2021)

Attention-deficit/hyperactive disorder updates
por: Kessi, Miriam, et al.
Publicado: (2022)

Serum Levels of Interleukin-6 and Tumor Necrosis Factor Alpha in Children With Attention-Deficit Hyperactivity Disorder
por: Elsadek, Akram E., et al.
Publicado: (2020)

Attention deficit hyperactivity disorder (ADHD) & COVID-19: Attention deficit hyperactivity disorder: Consequences of the 1st wave
por: Insa, I., et al.
Publicado: (2021)

Topiramate (Topamax): Evolving Role in Weight Reduction Management: A Narrative Review
por: Wajid, Irza, et al.
Publicado: (2023)

Why the Diagnosis of Attention Deficit Hyperactivity Disorder Matters
por: Hamed, Alaa M., et al.
Publicado: (2015)

Assessment of the lamina cribrosa in attention-deficit hyperactivity disorder
por: Akkaya, Serkan, et al.
Publicado: (2021)

Overview of Median Arcuate Ligament Syndrome: A Narrative Review
por: Upshaw, Will, et al.
Publicado: (2023)

Training of attention functions in children with attention deficit hyperactivity disorder
por: Tucha, Oliver, et al.
Publicado: (2011)

Connectivity supporting attention in children with attention deficit hyperactivity disorder
por: Barber, Anita D., et al.
Publicado: (2014)

Attention Patterns in Children with Attention Deficit Disorder with or without Hyperactivity
por: Zalsman, Gil, et al.
Publicado: (2003)

Neurophysiological Correlates of Attentional Fluctuation in Attention-Deficit/Hyperactivity Disorder
por: Cheung, Celeste H. M., et al.
Publicado: (2017)

Treatment of adults with attention-deficit/hyperactivity disorder
por: Kolar, Dusan, et al.
Publicado: (2008)

Treatment of adults with attention-deficit/hyperactivity disorder
por: Kolar, Dusan, et al.
Publicado: (2008)

Animal models of attention-deficit hyperactivity disorder
por: Russell, Vivienne A, et al.
Publicado: (2005)

Attention Deficit Hyperactivity Disorder in Epileptic Children
por: Kim, Gun-Ha, et al.
Publicado: (2012)

Attention-deficit/hyperactivity disorder in postsecondary students
por: Nugent, Kevin, et al.
Publicado: (2014)

What causes attention deficit hyperactivity disorder?
por: Thapar, Anita, et al.
Publicado: (2012)

Interoceptive awareness in attention deficit hyperactivity disorder
por: Wiersema, Jan R., et al.
Publicado: (2018)

Chiari Malformation and Attention Deficit Hyperactivity Disorder
por: DuBow, Anaïs, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q05j89splm1moimt35rv87cos6